Dalriada Therapeutics' Seed Round

Dalriada Therapeutics raised a round of funding on February 20, 2018. Investors include Fight Against Cancer Innovation Trust.

Dalriada Therapeutics is a pharmaceutical company focusing on the development of small molecule-based anti-cancer therapeutics. It is conducting preclinical and early clinical development of its uniqu…

Articles about Dalriada Therapeutics' Seed Round: